Search
for
Sort by
Research 16
- Cutaneous Toxicities From Transplantation-Related Medications
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Supplementary Material for: Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Supplementary Material for: Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- The role of lymphocytes in the development and treatment of alopecia areata
- Chemically Induced Hair Loss/Alopecia
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin
- The Many Faces of Calcineurin Inhibitor Toxicity—What the FK?
- Genetic Basis of Alopecia Areata
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Long‐term outcome after hand and forearm transplantation – a retrospective study
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- Immune therapies for alopecia areata: evidence and new perspectives
- Tacrolimus monitoring in hair samples of kidney transplant recipients